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Abstract At a time when the Health Effects Institute,
Centers for Disease Control, and Environmental Protection
Agency are creating an Environmental Public Health
Tracking Program on Air Pollution Effects in the USA, it
seemed useful to share the experience acquired since 1999
by the Apheis project (Air Pollution and Health—A
European Information System), which has tracked the
effects of air pollution on health in 26 European cities and
continues to do so as the new Aphekom project. In
particular, this paper first describes the continuing impact
of air pollution on health in Europe, how the Apheis project
came to be and evolved, what its main objectives and
achievements have been, and how the project benefited its
participants. The paper then summarizes the main learnings
of the Apheis project.
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Introduction
At a time when the Health Effects Institute, Centers for
Disease Control, and Environmental Protection Agency are
creating an Environmental Public Health Tracking (EPHT)
Program on air pollution effects in the USA, it seemed
useful to share the experience acquired since 1999 by the
Apheis project (Air Pollution and Health—A European
Information System)
1, which has tracked the effects of air
pollution on health in 26 European cities and continues to
do so as the new Aphekom project.
This paper first describes the continuing impact of air
pollution on health in Europe, how the Apheis project came
to be and evolved, what its main objectives and achieve-
ments were, and how the project benefited its participants.
The paper then summarizes the main learnings of the
Apheis project that are relevant to the EPHT Program.
The need for tracking
Air pollution continues to threaten public health
Numerous studies and the lack of effective policies reveal
that air pollution continues to threaten public health in
Europe today. As but a few examples:
1. A study (Künzli et al. 2000) published in The Lancet
revealed that roughly 40,000 people were dying every
year from the effects of air pollution in three European
countries alone, costing them some €50 billion annually
(Sommer et al. 2000).
2. Thecost–benefitanalysisofCleanAirForEurope(CAFE;
European Commission 2005) estimated 3.7 million years
of life lost each year (based on the year 2000) associated
with exposure to PM2.5 across the European Union’s
25 countries, or 348,000 estimated premature deaths
in Europe every year; 100,000 cases of respiratory or
1 Apheis is co-funded by the Pollution-Related Diseases Program of
the DG SANCO of the European Commission (contract nos.
SI2.131174 [99CVF2-604], SI2.297300 [2000CVG2-607], and
SI2.326507 [2001CVG2-602]) and participating institutes.
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DOI 10.1007/s11869-009-0050-2cardiac hospital admissions; 30 million respiratory
medication use days; and several hundred million
restricted-activity days each year.
3. On December 12, 2007, according to its press release,
“The European Parliament adopted a second-reading
legislative report which provides the maximum con-
centration levels for PM2.5. The report is the basis of an
agreement with the Council on a directive on air quality
(CAFE Directive).”
Commenting on the proposed CAFE Directive, scientists
had previously said, “As it stands, this new Directive would
mark a serious reduction in public health protection from
air pollution within the Member States, with health impacts
amounting to thousands of premature deaths per year.”
(Declaration on Need for Stricter European Regulation of
Air Pollution, ISEE–ISEA and IRS Munich and Paris,
September 4, 2006)
Key users lack vital information
Before the Aphea research project (Short-Term Effects of
Air Pollution and Health: A European Approach) began in
1993, European policy makers who directly influenced the
reduction of air pollution and its impact on health relied
mainly on American research for their information because
little European data was available. They also relied on
individual studies that did not use common methodology.
As a result, they could not compare research findings and
draw synthetic conclusions.
The Aphea project addressed these problems by providing
new, reliable European research data on the effects of air
pollution on public health and by instituting a standardized,
common methodology acrossdifferentcountries (Katsouyanni
et al. 1996, 2001).
However, being limited in time, Aphea was not designed
to provide information for environmental health profes-
sionals on an ongoing basis. In addition, policy makers,
healthcare providers, patient organizations, and the general
public lacked both information on the impact of air
pollution on health and the communications tools that
deliver that information to them—a l lt a i l o r e dt ot h e i r
specific needs.
The Apheis approach
Given this situation, we designed the Apheis project to help
all these audiences make better-informed decisions about
the political, professional, and personal issues they face in
this area. For this purpose, Apheis sought to expand
knowledge and understanding among these audiences of
the impact of urban air pollution on health by providing
them with an up-to-date, easy-to-use information resource
on the subject.
The plan: 26 centers across Europe gathered and analyzed
information on an ongoing basis, and communicated
it to key audiences
Apheis developed a public health surveillance system
(Teutsch and Churchill 1994) to provide information at
regular intervals on the effects of air pollution on health
tailored to the needs of its audiences.
For this purpose, Apheis built on previous experience
acquired in France, creating information systems on air
pollution and public health through the ERPURS project
(Medina et al. 1997), which has monitored the effects of
air pollution on public health in the Paris metropolitan area
since 1994, and through the subsequent PSAS program,
which began in 1997 (Quénel et al. 1999;H o s te ta l .
2007).
The Apheis public health surveillance system specifically:
quantified the effects of air pollution on public health at the
local and European levels; assessed the importance of factors
that can influence concentration–response (C–R) functions;
and delivered standardized, periodic reports on the impact of
air pollution on public health.
Apheis 1
During its first phase starting in 1999, Apheis achieved two
key objectives:
First, it defined the best indicators for health impact
assessment (HIA) of the effects of air pollution in Europe.
For this purpose, Apheis created five advisory groups in the
fields of public health, health impact assessment, epidemi-
ology, exposure assessment, and statistics. These groups
drafted guidelines that defined the best indicators for public
health surveillance and provided standardized protocols for
data collection and analysis.
Second, it identified those entities best able to implement
the surveillance system in the 26 cities in 12 European
countries participating in the project (Fig. 1); understood
how the different entities could work together on the local,
national, and European levels; and assessed each entity’s
ability to implement an HIA of particulate pollution using
the guidelines drafted by the advisory groups (Medina et al.
2001).
Apheis 2
During its second phase, Apheis implemented its organiza-
tional model (Fig. 2). Among other tasks, Apheis also used
186 Air Qual Atmos Health (2009) 2:185–198its public health surveillance system to conduct an HIA of
PM10 and black smoke (BS), applying the above guidelines
to gathering and analyzing pertinent data. For the HIA,
Apheis provided all the centers with HIA methods and
tools, and a template for the city-by-city HIA reports.
ThisfirstHIAfoundthatbetween500and1,000premature
deaths could be postponed annually if, all other things being
equal, short-term exposure to outdoor concentrations of PM10
were reduced by 5 μg/m
3 in Apheis cities. The expected
benefits of reduction in mortality in the long term were
greater: the HIA estimated that, all other things being equal,
between 3,400 and 7,700 premature deaths could be
postponed annually if long-term exposure to outdoor
concentrations of PM10 had been reduced by 5 μg/m
3 in
each city. Apheis published the findings of this work in its
second-year report (Medina et al. 2002) and in a scientific
paper (Medina et al. 2004).
Apheis 3
In its third phase, in 2003–2004, Apheis started developing
a communications strategy and updated its HIAs through its
public health surveillance system.
Fig. 1 The Apheis network
Air Qual Atmos Health (2009) 2:185–198 187Developing an Apheis communications strategy
“The DETR (UK Department of the Environment,
Transport and the Regions) has had little success
ensuring that anyone takes notice of the information
provided.”–Dr. Erik Millstone, Science and Tech-
nology Policy Unit, Sussex University
As already stated, the Apheis project sought to meet the
information needs of a wide range of individuals and organi-
zations concerned with the impact of air pollution on health in
Europe and, as a first step, to meet the needs of those individ-
uals who influence and set policy in this area on the European,
national, regional, and local levels. Like other providers of
scientific information, however, Apheis had reason to believe
that its many audiences, policy advisors and makers in partic-
ular, were making little use of the scientific reports it produces.
To ensure it met the needs of policy advisors and
makers, Apheis decided to develop a communications
strategy based on learning directly from the members of
this key audience their needs and the usefulness to them of
the Apheis 2 report. For this purpose, Apheis interviewed
32 individuals who influence or set policy on air pollution
and health in the UK and Spain and who are active in the
fields of public health and the environment.
Through this research, Apheis sought to describe this
audience’s information needs as accurately as possible, and
then produce recommendations for developing communi-
cations tools that would help the audience’s members best
understand, absorb, process, and act on the information
Apheis provides.
Our research showed in particular that (Fig. 3) policy
advisors and makers generally are unlikely to use the
scientific reports we develop as is, different from scientists.
It also showed that a long, complex chain comprising many
players leads from the scientists to whom we distribute our
reports directly, and who use them, to the policy makers
who ultimately have the greatest effect on public health, but
who only receive our reports indirectly and use them rarely,
if at all. Lastly, we learned that each of our two audiences
of scientific and policy users has different problems to
solve, different levels of scientific knowledge and different
cultures, and different ways of processing information for
themselves and for pass-on users, meaning each audience
has different information needs.
Based on this evidence, we concluded that Apheis
needed to act proactively to apply this knowledge to the
way it shapes and delivers its information and messages by
developing a range of communications tools that goes
beyond our comprehensive scientific reports to include
summary reports, brochures, presentations, and Q&As
whose focus, content, and form are tailored to the separate
information needs of scientific and policy users. In addition,
Apheis needed to ensure that the information required by
policy advisors and makers actually reaches them.
Taking these steps greatly enhanced the way Apheis
communicated with the key audiences that set policy on air
pollution in Europe, and thus helped Apheis contribute
better to improving public health.
Updating the Apheis health impact assessment
Tables 1 and 2 summarize the HIA scenarios developed in
Apheis 3. Once again, Apheis provided all its centers with
HIA methods and tools, and a template for the city-by-city
HIA reports.
Key HIA findings
During Apheis 3, we updated the estimates of the effects of
air pollution on health. We established new all-ages
respiratory C–R functions suitable for HIA. We introduced
methodological innovations to improve the estimated
impacts of short-term changes in exposure to air pollution.
And we calculated reduction of life expectancy, beside the
absolute number of cases, to estimate the health impacts of
long-term exposure to air pollution.
Inthe23citiesmeasuringPM10, totaling almost 36 million
European inhabitants, Apheis 3 revealed that, all other things
being equal, if exposure to outdoor concentrations of raw
PM10
2 was reduced to 20 µg/m
3 in each city:
& More than 2,500 premature deaths (including some
1,700 cardiovascular and 400 respiratory deaths) could
European coordination
center and comanager
Steering committee
Advisory Groups
Exposure assessment
Epidemiology
Statistics
Public Health
Health Impact Assess
Information system
manager
Participating European Centre
Technical  Committee (Core)
Exposure assessment
Epidemiology
Statistics
Public Health
Health Impact Assessment
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Institutional (Steering) Committee
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Medical /Environmental Sciences
Citizens/NGO
Local/Regional coordinator
Fig. 2 Apheis general organizational model and functions
2 For HIAs of short-term exposure, we used raw PM10 and BS levels
measured directly at monitoring stations.
188 Air Qual Atmos Health (2009) 2:185–198potentially be postponed annually when the impact
estimation was limited to 2 days of follow-up.
& The short-term impact cumulated over 40 days was
more than twice as large, amounting to over 5,200 total
deaths (including some 3,400 cardiovascular and 1,300
respiratory deaths).
& Long-term effects of pollution reduction were higher.
Our HIA estimated that reduction of long-term exposure
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190 Air Qual Atmos Health (2009) 2:185–198to corrected PM10
3 would result in postponing more
than 21,300 premature deaths annually.
Stated otherwise, for both total and cause-specific
mortality, the benefit of reducing converted PM2.5
4 levels
to 15 µg/m
3 was more than 30% greater than for a
reduction to 20 µg/m
3. However, even at 15 µg/m
3,a
significant health impact was expected.
In terms of life expectancy, all other things being equal,
if the annual mean of PM2.5 converted from PM10
4 did not
exceed 15 µg/m
3 in the 23 cities measuring PM10, the
expected gain in life expectancy of a 30-year-old person
would range, on average, between 2 and 13 months due to
reduced risk of death from all causes. An example of the
impact in terms of life expectancy in Seville is shown in
Fig. 4.
For those wanting to know the contribution of air
pollution to the total burden of mortality in the Apheis
cities, particulate pollution contributed in a non-negligible
manner to this burden. All other things being equal, when
only considering very short-term exposure, the proportion of
all-cause mortality attributable to a reduction to 20 μg/m
3 in
raw PM10 levels would be 0.9% of the total burden of
mortality. This proportion would be greater (1.8%) for a
cumulative short-term exposure up to 40 days. Effects of
long-term reduction in corrected PM10 levels would account
for 7.2% of the burden of mortality.
For long-term exposure to PM2.5 converted from cor-
rected PM10, all other things being equal, the proportion of
all-cause mortality attributable to a reduction to 20 μg/m
3
in converted PM2.5 levels would be 4% of the total burden
of mortality (Boldo et al. 2006).
Apheis also noted that, from a public health perspective,
the health impact of daily exposure to air pollution in the
long run is greater than the exposure to air pollution peaks
(Fig. 5).
Interpretation
In order to provide a conservative, overall picture of the
impact of urban air pollution on public health in Europe, like
its predecessor Apheis 2, the Apheis 3 project used a limited
number of air pollutants and health outcomes for its HIAs.
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3 For HIAs of long-term exposure, because the exposure-response
functions used are taken from a publication that used gravimetric
methods (Pope et al. 2002), for consistency we had to correct the
automatic PM10 measurements used by most of the cities by a specific
correction factor (local or, by default, the European factor of 1.3) in
order to compensate for losses of volatile particulate matter.
4 For most of the cities, PM2.5 measurements were not available, and
PM2.5 levels had to be calculated from PM10 measurements. For this
purpose, a conversion factor (local or, by default, the European factor
of 0.7) was used.
Air Qual Atmos Health (2009) 2:185–198 191Apheis 3 also established a basis for comparing methods
and findings between cities, and explored important HIA
methodological issues through sensitivity analyses to gain a
better sense of the overall uncertainty of our estimates
(WHO 2000, 2001; Le Tertre et al. 2005).
Below we discuss these methodological considerations
as they apply to exposure assessment, health outcomes and
baseline rates, and C–R functions.
Exposure assessment
OurHIAfindingsdependeddirectlyonthelevelsofparticulate
pollution measured. These levels vary widely as a function of
the number and location of the monitoring sites, the analytical
methods used, and the sites selected for our HIA.
In order to harmonize and compare the information
relevant to exposure assessment by the 26 Apheis cities, the
exposure measurements used in Apheis 3 were interpreted
in accordance with the Apheis guidelines on exposure
assessment. In particular, we verified the total number and
type of monitoring stations and the number of stations used
for HIA purposes, the measurement methods, the use of a
correction and/or conversion factor, and data quality.
Measurement intervals for air quality indicators Because
the C–R functions selected for HIAs of short-term exposure
use the 24-h average measurement interval, the Apheis
guidelines recommended 24-h averages for PM10,P M 2.5,
and BS, and the Apheis cities complied with the given
recommendations for all monitoring stations. For HIAs of
long-term exposure, the C–R functions selected used annual
levels, so the Apheis cities did likewise.
Number of stations and site selection Altogether, 142
monitoring stations were selected for HIAs in accordance
with the Apheis site-selection criteria. In a few cities, only
one or two stations were used, but these were background
stations and could only partially reflect the population
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192 Air Qual Atmos Health (2009) 2:185–198exposure. In three cities, 28 stations were classified as
directly traffic-related and should theoretically be excluded
from HIA calculations. However, the data from these
stations was used for HIA because: (1) local experts
considered the data from the stations was the most
representative of the population’s exposure in those cities;
(2) C–R functions used for HIA of short-term exposure
used these direct traffic-related stations, but studies selected
for HIAs of long-term exposure did not use these stations.
Measurement methods The Apheis centers reported the
PM10/PM2.5/BS/total suspended particulate (TSP) measure-
ment methods in full, and used automatic PM10 measure-
ment methods (the β-ray absorption method and the tapered
oscillating microbalance method, TEOM). PM2.5 measure-
ments were done only by TEOM. Reflectometry is the
commonly used measurement method for BS. TSP was
measured by the β-ray absorption method in one city and
by the gravimetric method in another city.
Local or, by default, European correction factors for
PM10 were used for the purpose of long-term HIAs in order
to compensate for losses of volatile particulate matter. In
general, local conversion factors were slightly lower than
the European factor of 1.3 recommended by the EC
Working Group on Particulate Matter.
Besides this correction factor, conversion factors (local
or European) were given for calculating PM10 from TSP
measurements as well as for PM2.5 data calculated from
PM10 measurements. The default factor of 0.7 for PM2.5
was recommended by the Apheis Exposure Assessment
working group. In most of the Apheis cities that could
compare both the annual mean levels of PM2.5 measured
directly and PM2.5 converted from PM10 calculated using
the European conversion factor (0.7), the annual mean level
ofPM2.5 measured directly was a little lower than the annual
mean level of PM2.5 converted from PM10 calculated using
the European conversion factor.
In conclusion, the assessment of exposure data in Apheis
3 was sufficiently reliable overall for our HIA purposes.
Health outcomes
The Apheis centers provided a full description of the health
indicators used for Apheis 3, the type of sources, the
coverage, the existence of a quality-control program, the
type of coding used, and the completeness of the data.
Mortality data For mortality data we used the national,
regional, or local mortality registries for all the cities. In
Apheis 3, cause-specific mortality was included beside all-
cause mortality to enrich the mortality picture. But all-cause
mortality remains our first choice because it is more robust,
not subject to misclassification, and easier to obtain.
Because most of the cities applied a quality-control
program and because there is a low percentage of missing
data for all-cause mortality, we consider that erroneous
entries in the selection of cause of death did not affect the
comparability of the data between cities.
Hospital admissions data To estimate the acute effects of
short-term exposure to air pollution on hospital admissions,
in each city we selected hospital admissions for residents
with discharge diagnoses of respiratory diseases (ICD9=
460–519; ICD10=J00–J99) and cardiac diseases (ICD9=
390–429; ICD10=I00–I52). Whenever possible, only
emergency admissions were selected as being more
specifically related to air pollution, and discharge diagnoses
were used in all cases because they are more reliable.
All the cities obtained hospital admissions data from
registries. The completeness of the registries on hospital
admissionswas quite high; 95% ormorein18ofthe 22cities.
All the registries run a quality-control program, and
completeness in the diagnosis for the cause of admission
was high, with a percentage of missing data of 1% or lower
for 19 of the 22 registries.
The main problem for comparability was the difference
in availability of information in the registries, because some
cities used emergency admissions while others that lacked
this information used general admissions.
Methodologically speaking, statistical analyses of the
Aphea 2 cities showed no significant heterogeneity in the
estimated relative risk (RR) of hospital admissions between
cities that reported general hospital admissions and cities
that reported emergency hospital admissions only (Atkinson
et al. 2001; Le Tertre et al. 2002).
Nevertheless, there is an issue for HIA if general
admissions are used rather than emergency admissions
and the same RR is applied. We should investigate the
possibility of using a correction factor from emergency
admissions and apply it to general admissions. There is
also a need to examine this and other approaches on how
to best handle the difficult situation of HIA when
baseline data is unknown, missing, or collected in
different ways.
The analysis of health-data quality and availability
concluded that, for local use in each city, the selected data
was reliable. When comparing findings between cities, the
data was fully comparable for the selected categories of
mortality. Nevertheless, even if most of the cities had
hospital data from registries that use a quality-control
program, such comparability was limited for the incidence
of hospital admissions. The incidence rates for emergency
and total admissions (Fig. 6) appeared not to be fully
comparable. Consequently, we presented data for hospital
admissions and the resulting HIAs in the city-by-city reports
only. The follow-on Aphekom project is investigating the
Air Qual Atmos Health (2009) 2:185–198 193influence of healthcare and health-monitoring systems on
morbidity data for HIAs.
Concentration–response functions
Most HIAs, including ours, use overall estimates from
multi-center studies. But in some cases, people prefer to use
city-specific estimates when they conduct an HIA in a city
where an epidemiological study has been done that
provides local E–R functions. Apheis discussed the
alternative use of city-specific estimates, and the statistical
advisory group conducted a sensitivity analysis using
different effect estimates (Le Tertre et al. 2005).
Sensitivity analysis using different types of estimates The
Apheis statistical advisory group conducted a sensitivity
analysis in some cities using different effect estimates
(observed city-specific, shrunken city-specific, pooled,
mixture of shrunken city-specific and adjusted for effect
modifiers) to calculate the number of premature deaths in
each city. The study concluded that, although the sum for
21 European cities of the deaths attributable to PM10 is not
strongly influenced by the method used to estimate RRs,
this is not true at the city level.
Applied to a single city, the different estimates tested
presented benefits and limits. Based on these limitations,
the authors recommended the use of the shrunken estimate
in cities for which this option was available. Use of this
shrunken estimate enabled deriving the overall estimate at
the local level by combining information from the city-
specific estimate and the overall estimate, and can be
considered as a weighted mean between these two
estimates. Use of this shrunken estimate also reduced the
variability of the local estimate by incorporating informa-
tion from other cities. However, a key disadvantage of
using such an estimate is that it can only be applied in cities
that are part of the initial multi-center analysis.
Figure 7 shows the estimated density for each of the
shrunken estimators (i.e., in each city). Superimposed is the
estimated distribution of the pooled estimate (i.e., overall),
based on the random effects model and the estimated
mixture distribution of the Empirical Bayes estimates
across all the cities.
Substantial departures from the population mean (over-
all) estimate can be seen in several cities. The underlying
distribution of the Empirical Bayes estimates displays the
same mean as the pooled estimate, but it is more flat,
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194 Air Qual Atmos Health (2009) 2:185–198reflecting the heterogeneity between cities. Consequently,
the corresponding 95% credible interval for the RR for total
mortality associated with a 10 µg/m
3 increase in PM10
(0.994, 1.014) is larger than the one derived from the
pooled estimate (1.002–1.006).
The statistical advisory group recommended using an
estimated mixture distribution of the shrunken estimates
that will give the same central estimate as the overall
pooled one but with a larger confidence interval, avoiding
excessive certainty suggested by naïve approaches to risk
assessment. Use of this type of estimate was proposed at the
city level in future HIAs.
When building our own C–R functions on respiratory
admissions of all ages, we used the Aphea 2 methodology
(Katsouyanni et al 2001) based on time-series analysis,
taking into account the problems with generalized additive
models raised by the National Mortality and Morbidity Air
Pollution Study (Dominici et al. 2002) and investigating the
sensitivities of the estimated pollution effects by using
alternative smoothing techniques, parametric and non-
parametric, and by using a range of smoothing parameters.
Since we used aggregated data in Apheis, we preferred
using a time-series approach instead of case-crossover
analysis. In addition, only a time-series approach can take
overdispersion into account (Lu and Zeger 2007).
Starting in June 2008, Apheis continued investigating
important methodological issues and uncertainties sur-
rounding HIA findings in the new EC co-funded project
called Aphekom.
Achievements of the Apheis project
The Apheis project has created an active public health and
environmental network that facilitates the flow of informa-
tion between environmental and health professionals. It has
developed expertise across Europe. It has guided and
optimized the measurement of air pollutants by local air-
quality-monitoring networks so these networks meet the
needs of public health monitoring.
Apheis has also contributed to training environmental
health professionals. It has provided information to evaluate
the effectiveness of different scenarios for reducing air
pollution levels on local, national, and European levels.
Lastly, Apheis has gained recognition from local and
national authorities as able to provide sound scientific
advice on health risks related to air pollution. And Apheis
has interested cities in joining the Apheis network who
were not previously involved in the Apheis project.
Impact of the Apheis project
Implications for EU policy making
To contribute to the discussions between the European
Council and the Parliament on new limit values for PM2.5,
the Apheis project estimated the potential benefits in terms
of deaths that could be postponed in 26 European cities by
reducing PM2.5 annual levels to 25, 20, 15, and 10 μg/m
3,
respectively. In particular, reducing annual mean levels of
PM2.5 to 15 μg/m
3 could postpone three times more
premature deaths in the Apheis cities than a reduction to
25 μg/m
3 (13,200 vs. 4,400 deaths; Fig. 8). This factor
could grow from three times to five times if PM2.5 levels
were reduced to 10 μg/m
3 (22,200 vs. 4,400 deaths). Apheis
also made a sensitivity analysis to check the changes in HIA
estimates using other C–R functions or other correction
factors for the ratio of PM2.5/PM10. The main conclusions
here remained the same (Ballester et al. 2008).
Impact of the project on the centers’ work and on local
policy making
Impact on the centers’ work
The Apheis centers learned the philosophy, methods, and
tools of the HIA approach.
The Apheis project improved the scoping, appraisal, and
reporting of HIA stages.
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Air Qual Atmos Health (2009) 2:185–198 195The project provided an opportunity to harmonize
existing local and national approaches to HIA. And Apheis
enabled many cities to conduct enlarged local, regional, and
national HIAs. Feedback we received told us that Apheis
“stimulated us to go further with both national and local
HIAs” and obtain funding for this purpose (according to the
centers in Stockholm and Gothenburg, Sweden and in
Andalusia, Spain).
Apheis locally fostered dialog between environment and
health professionals. Apheis also led to the exchange of
know-how in different fields at the EU level. And the
Apheis project enabled centers to meet with international
experts and create lasting relationships, contributing to “A
significant impact due to the international dimensions of the
project” (Bucharest, Romania).
Involvement in the Apheis project made local findings
more credible. And Apheis provided the centers with “a
stimulus from the outside” that facilitated local work on air
pollution and health. As an example, “Involvement in the
Apheis project increased the prestige of our team” (Madrid,
Spain).
The Apheis centers valued being able to compare findings
with those of other cities: “Use of international benchmark-
ing was a good starting point for a science-based discussion
of the overall and local results” (Hamburg, Germany).
Apheis provided an opportunity to apply HIA to other
fields, e.g., domestic heating (Vienna, Austria), and opened
doors for related HIA projects (Stockholm and Gothenburg,
Sweden).
The Enhis and Enhis 2 projects applied Apheis method-
ology to develop an online tool for the HIA of urban air
pollution using European databases and/or local data.
Impact on local policy making
Apheis findings contributed to local, regional, and national
environmental health action plans. And local centers were
asked to speak to local and national authorities. According
to feedback, with Apheis “We can show people and policy
makers a clear result about impact of air pollution on health.”
“Apheis findings are very helpful in the current discussion on
reducing air pollution in big cities” (Ljubljana, Slovenia).
“Apheis findings, beside other results on the impact of air
pollution on health, led the Spanish Government to approve
the new Law on Air Quality” (Valencia, Spain).
Apheis raised awareness through the mass media and
NGOs. In particular, HIA findings were easier to commu-
nicate than other findings (Stockholm and Gothenburg,
Sweden). “The results of Apheis were always attractive for
journalists, much more than telling them about RRs or ORs
(odd ratios). So HIA provides a very useful tool for
informing the public” (Athens, Greece). “The picture with
air pollution influence on life expectancy had a huge impact
in the Netherlands. It was very helpful to translate scientific
information into pictures” (Rotterdam, Netherlands). “The
assessment of long-term impact of air pollution, especially
years of life lost, was extremely useful for us” in terms of
communication (Budapest, Hungary).
“Apheis creates a good framework in which results can
be properly assessed and compared with others from similar
and different places” (Bilbao, Spain). “We used the Apheis
information for benchmarking, which is very important for
civil servants and politicians who want to know if they have
unique problems or if problems are similar in other cities”
(Rotterdam, Netherlands).
Problems remained
While Apheis sought to increase awareness of the impact of
air pollution on health, there has generally been little
change in behavior. In some countries, Apheis findings had
little impact because of higher national priorities (Israel)
and because other sources of information on the effects of
air pollution on health were available (Rome, London).
In addition, centers were concerned by the EU’s lack of
willingness to fund a European system for monitoring the
effects of air pollution on health on a continuous basis.
Conclusions for the EPHT Program and other projects
Based on our experience with the Apheis project, we
believe the following steps are key to the success of the
EPHT Program on air pollution:
& Build a collaborative network from the bottom up to
stimulate cooperation and facilitate decision making on
thelocal,national,andhigherregionallevels.Inparticular,
we suggest that all network members contribute actively
to the program’s work and be encouraged to take
ownership by being consulted on all important decisions.
& Use standardized protocols and tools for data collection
(short and long term) and HIA analysis. It is essential
that everyone use the same definitions for the geo-
graphical areas studied, the exposure measurements
used, the health indicators selected, and the analytical
methods used for HIAs to ensure comparability of
methods and findings between cities.
& Because this is a public health program and not a
research project, it is important to keep things simple to
ensure feasibility and compliance in the long term. But
it is equally important to use rigorous methods and keep
the quality of work high, while discussing sources of
uncertainties with stakeholders.
& Local committees should be involved from the outset.
In particular, we feel it is important that all potential
196 Air Qual Atmos Health (2009) 2:185–198stakeholders be involved from the project’s inception by
informing them of the program’s progress and getting
their input on the project as it evolves.
& Ongoing cross-fertilization should be fostered between
multiple disciplines and regions to create skilled, local
teams; enrich know-how and the quality of its findings;
and explore HIA methodological issues. In particular, this
means sharing experiences among the program’sp a r t i c -
ipants by organizing meetings, thematic workshops, and
forums for discussing specific issues in methodology.
& Finally, however, remember that public health findings
continue to have a limited impact on policy making,
since decision makers are influenced by other factors
they consider to be more important when setting policy.
Hence, the EPHT Program might consider putting more
emphasis on how to package public health findings
convincingly for the needs of government policy
makers and influencers. And for this purpose, use the
knowledge and expertise of skilled communication-
strategy professionals.
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